April.2020-March.2021

Publication of a paper describing a phase 2 study of cancer vaccine OCV-C01 in patients with biliary tract cancer

Announcement of the presentation of results for Phase II study of S-588410 in bladder cancer at ASCO GU 2021

The announcement of the initiation of Phase I clinical study of OTS167 for breast cancer patients in Japan

The initiation of COVID-19 peptide vaccine R&D project

The press release from Kindai University regarding Phase II cancer-specific peptide vaccine therapy (investigator-initiated clinical trial) for esophageal cancer patients

Publication of a scientific paper about liquid biopsy

Publication of a case study supported by Cancer Precision Medicine for the neoantigen and TCR repertoire analyses

Announcement of the press release from Keio University School of Medicine regarding the publication of immunotherapy for neurofibromatosis type 2 (NF2)

Announcement of an additional investigational site opening for the Phase I clinical study of combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer